Description

▪ Introduction

Halostate by Proton Pharma contains Fluoxymesterone, a potent synthetic anabolic-androgenic compound originally developed for clinical applications such as treating male hypogonadism and delayed puberty. In laboratory settings, Fluoxymesterone is studied for its high androgenic index, influence on strength parameters, and resistance to estrogenic activity. This pharmaceutical-grade formulation ensures consistent quality and is intended solely for laboratory and analytical use.

▪ Product Details (Bulleted)

• Active Ingredient: Fluoxymesterone

• Dosage Strength: 10 mg per tablet

• Form: Oral tablets

• Brand: Proton Pharma

• Package Size: 60 tablets

• Intended Use: Laboratory and analytical use

▪ Pharmacokinetics

Fluoxymesterone is rapidly absorbed via oral administration, with a biological half-life of approximately 9 hours. It is primarily metabolized in the liver and exhibits potent androgenic activity with minimal aromatization to estrogen. These properties make it a focus of studies related to androgenic signaling and hormonal modulation in controlled environments.

▪ Usage Recommendations

• Typical Experimental Dosage (historic/clinical context): Used under medical supervision for conditions such as hypogonadism and anemia

• Current Use: For laboratory and analytical research only

• Administration: Oral administration once or twice daily, depending on research protocols

▪ Disclaimer

This product is intended strictly for laboratory and analytical research use. It is not approved for human consumption or therapeutic application. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with any underlying health conditions. All research must comply with local regulations, institutional protocols, and professional standards.